Dr. Dorry Segev has recently concluded multiple studies that looked at the immune response to COVID-19 vaccination in kidney transplant recipients. In this episode, Sam Kant (our new Life as a Nephrologist co-host) and Dorry Segev discuss these pivotal studies including the process, results, and directions going forward. Lastly, they discuss breakthrough infections.

List of study’s discussed:

• Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

Dorry Segev, MD, PhD, is a Professor of Surgery and Epidemiology and Associate Vice Chair of Surgery at Johns Hopkins University. He has published over 650 peer-reviewed research articles, and is ranked #1 worldwide in organ transplantation expertise and influence by ExpertScape. Reflecting his contributions to health care, he was recently elected into the National Academy of Medicine. Reflecting the creativity and broad reach of his contributions, he received a prestigious Global Thinker Award from Foreign Policy Magazine and was named an Innovators of the Year by TIME Magazine. His work has directly influenced policy, including two Congressional bills (the Norwood Act for kidney exchange and the HOPE Act for HIV-to-HIV transplants), and is regularly featured in widely read media including several front-page features in the New York Times. In the context of the pandemic, Dr. Segev has shifted his research to better understanding coronavirus and its implications in solid organ transplantation.

We are bringing on a new co-host for this episode, please help us welcome Sam Kant, MD! He is a transplant nephrology fellow at Johns Hopkins University School of Medicine. He has completed nephrology fellowship at Johns Hopkins, internal medicine residency and chief residency at University of Maryland. His research interests include ANCA vasculitis, transplantation and has been a recipient of multiple awards in the realm of education. He is also the chair of the American College of Physicians Young Physician Council, co-editor of the Renal Fellow Network and editorial board member of American Society of Nephrology Kidney News. Additionally, he is a member of the planning committee for the 2022 NKF Spring Clinical Meetings.